Qlucore Insights Can Classify Primary Lung Samples, Metastatic Lesions
Qlucore has released a new version of Qlucore Insights tailored for lung cancer, capable of classifying both primary and metastatic lesions.
Read MorePosted by Chris Wolski | May 23, 2024 | Cancer |
Qlucore has released a new version of Qlucore Insights tailored for lung cancer, capable of classifying both primary and metastatic lesions.
Read MorePosted by Andy Lundin | May 21, 2024 | Sequencing Systems |
Foundation Medicine launched a tissue-based RNA sequencing test in the U.S. for the detection of cancer-related fusions across 318 genes.
Read MorePosted by Andy Lundin | May 20, 2024 | Infectious Diseases |
The Karius Test, a diagnostic tool for lung infections in immunocompromised patients, received Breakthrough Device Designation from the FDA.
Read MorePosted by Andy Lundin | May 13, 2024 | Lung Cancer |
OSF HealthCare will use DELFI’s FirstLook Lung blood test to enhance lung cancer screening rates and early detection efforts.
Read MorePosted by Andy Lundin | Apr 16, 2024 | Lung Cancer |
CAP developed recommendations for testing immunotherapy biomarkers, such as PD-L1 and TM), in patients with NSCLC.
Read More